4th Edition Strategic Alliance Management for Pharma

4th Edition Strategic Alliance Management for Pharma

16-06-2014 - 18-06-2014 Avenida Palace Hotel Barcelona, Spain

The 4th Edition Strategic Alliance Management for Pharma conference will look at how to transform alliances into flourishing revenue producing partnerships that align to business goals for all partners.

Why attend?

The 4th Edition Strategic Alliance Management for Pharma conference will look at how to transform alliances into flourishing revenue producing partnerships that align to business goals for all partners.

Delegates will benefit from unbeaten business models, case studies and learn how to become the partner of choice whilst having the capability to monitor the performance of their alliances.

All delegates will discover how to minimise the risks of alliances through tried and tested tools. The long ongoing cultural differences between academia, biotech and pharma will also be dealt with to help all parties negotiate ownership of products and tailor a flexible partnership agreement.

Key topics include:

  • Realign transforming alliances to successfully coordinate the activities of the R&D and related business functions
  • Gain cutting edge tried and tested tools to track alliance performances and measure KPIs
  • Evaluate and explore new alliance tactics that lead to optimal deal structures
  • Manage strategic global alliances to reach new markets and understand the challenges and opportunities
  • Overcome funding restraints and leverage strategies in securing corporate venture funds or venture capital

Who should attend:

CEO, COOs, Directors, Heads, Managers in:

  • Alliance Management
  • Transactions/Partnerships
  • Business Development
  • Corporate Development
  • Intellectual Property
  • Licensing
  • External Research
  • External Scientific Affairs
  • Strategic
  • External Strategy/Opportunities/Research
  • Open Innovation

COMPANY SPOTLIGHT

Parexel

Parexel

Oryzon Genomics

logo-oryzon.png

Oryzon Genomics is a Spanish clinical stage biopharmaceutical company.

Back to top